tiprankstipranks
Advertisement
Advertisement

NVCR Stock Latest News

NovoCure Earnings Call Highlights Growth, One-Time Hit
Company AnnouncementsNovoCure Earnings Call Highlights Growth, One-Time Hit
16h ago
NVCR
Novocure price target raised to $17 from $13.50 at Wells Fargo
PremiumThe Fly
Novocure price target raised to $17 from $13.50 at Wells Fargo
16d ago
NVCR
Novocure price target raised to $20 from $16 at Evercore ISI
PremiumThe Fly
Novocure price target raised to $20 from $16 at Evercore ISI
19d ago
NVCR
NovoCure Earnings Call Highlights Growth, One-Time Hit
PremiumCompany Announcements
NovoCure Earnings Call Highlights Growth, One-Time Hit
20d ago
NVCR
Midday Fly By: Alphabet, Meta, Amazon, Microsoft report quarterly beats
PremiumThe Fly
Midday Fly By: Alphabet, Meta, Amazon, Microsoft report quarterly beats
20d ago
UL
CAT
Novocure reports Q1 EPS (62c), consensus (51c)
PremiumThe FlyNovocure reports Q1 EPS (62c), consensus (51c)
20d ago
NVCR
Novocure raises FY26 revenue view to $690M-$710M from $675M-$705M
Premium
The Fly
Novocure raises FY26 revenue view to $690M-$710M from $675M-$705M
20d ago
NVCR
NovoCure Expands Executive Role, Adjusts CMO Compensation
Premium
Company Announcements
NovoCure Expands Executive Role, Adjusts CMO Compensation
1M ago
8K
NVCR
Novocure price target lowered to $16 from $23 at Evercore ISI
PremiumThe Fly
Novocure price target lowered to $16 from $23 at Evercore ISI
1M ago
NVCR
Zymeworks appoints Kristin Stafford as CFO
PremiumThe Fly
Zymeworks appoints Kristin Stafford as CFO
2M ago
NVCR
ZYME
NovoCure’s EF-32 Optune® Trial Reaches Completion, Setting Up a Key Catalyst for NVCR Investors
PremiumCompany Announcements
NovoCure’s EF-32 Optune® Trial Reaches Completion, Setting Up a Key Catalyst for NVCR Investors
2M ago
NVCR
NovoCure Announces Positive Phase 2 PANOVA-4 Pancreatic Cancer Data
PremiumCompany Announcements
NovoCure Announces Positive Phase 2 PANOVA-4 Pancreatic Cancer Data
2M ago
8K
NVCR
Novocure announces results from Phase 2 PANOVA-4 trial met primary endpoint
PremiumThe FlyNovocure announces results from Phase 2 PANOVA-4 trial met primary endpoint
2M ago
NVCR
Novocure gets reimbursement approval in Japan for Optune Lua
Premium
The Fly
Novocure gets reimbursement approval in Japan for Optune Lua
3M ago
NVCR
Novocure gets reimbursement approval in Japan for Optune Lua
Premium
The Fly
Novocure gets reimbursement approval in Japan for Optune Lua
3M ago
NVCR
NovoCure Earnings Call: Growth Builds Amid Profit Strain
PremiumCompany Announcements
NovoCure Earnings Call: Growth Builds Amid Profit Strain
3M ago
NVCR
Novocure reports Q4 EPS (22c), consensus (41c)
PremiumThe Fly
Novocure reports Q4 EPS (22c), consensus (41c)
3M ago
NVCR
Novocure sees FY26 revenue $675M-$705M, consensus $681.24M
PremiumThe Fly
Novocure sees FY26 revenue $675M-$705M, consensus $681.24M
3M ago
NVCR
Novocure says CMS rescinds revocation of billing privileges
PremiumThe Fly
Novocure says CMS rescinds revocation of billing privileges
3M ago
NVCR
Novocure jumps 11% after CMS reinstates Medicare billing privileges
PremiumThe FlyNovocure jumps 11% after CMS reinstates Medicare billing privileges
3M ago
NVCR
NovoCure Has Medicare Billing Privileges Reinstated by CMS
Premium
Company Announcements
NovoCure Has Medicare Billing Privileges Reinstated by CMS
3M ago
8K
NVCR
NVCR Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
NVCR Upcoming Earnings Report: What to Expect?
3M ago
NVCR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >